End of week summary

This week we covered the recent COVID-19 pandemic, how diagnostics were used during it and how procalcitonin was a useful biomarker. We also looked at the barriers and limitations of procalcitonin and how to address them. Finally, we summarised the link between procalcitonin and antimicrobial stewardship.

Take some time to consolidate your thoughts on this week’s learning and share your favourite parts of this week’s content in the comments.